Nu Skin Enterprises Inc
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements,… Read more
Nu Skin Enterprises Inc (NUS) - Total Liabilities
Latest total liabilities as of September 2025: $624.61 Million USD
Based on the latest financial reports, Nu Skin Enterprises Inc (NUS) has total liabilities worth $624.61 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nu Skin Enterprises Inc - Total Liabilities Trend (1995–2024)
This chart illustrates how Nu Skin Enterprises Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Nu Skin Enterprises Inc Competitors by Total Liabilities
The table below lists competitors of Nu Skin Enterprises Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥1.60 Billion |
|
Beijing Shengtong Printing Co Ltd
SHE:002599
|
China | CN¥897.77 Million |
|
CICOR TECHNOL.NAM. SF 10
F:CRLN
|
Germany | €347.12 Million |
|
Maxvision Technology Corp
SHE:002990
|
China | CN¥1.30 Billion |
|
SAMPYO Cement Co. Ltd
KQ:038500
|
Korea | ₩660.87 Billion |
|
Absci Corp
NASDAQ:ABSI
|
USA | $34.65 Million |
|
Wenzhou Hongfeng Electrical Alloy Co Ltd
SHE:300283
|
China | CN¥2.38 Billion |
Liability Composition Analysis (1995–2024)
This chart breaks down Nu Skin Enterprises Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.99 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.78 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.44 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nu Skin Enterprises Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nu Skin Enterprises Inc (1995–2024)
The table below shows the annual total liabilities of Nu Skin Enterprises Inc from 1995 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $817.46 Million | -16.97% |
| 2023-12-31 | $984.50 Million | +6.58% |
| 2022-12-31 | $923.67 Million | -7.05% |
| 2021-12-31 | $993.71 Million | -6.50% |
| 2020-12-31 | $1.06 Billion | +18.92% |
| 2019-12-31 | $893.72 Million | -2.07% |
| 2018-12-31 | $912.58 Million | +3.08% |
| 2017-12-31 | $885.28 Million | +9.30% |
| 2016-12-31 | $809.98 Million | +19.08% |
| 2015-12-31 | $680.22 Million | +1.22% |
| 2014-12-31 | $672.00 Million | -30.18% |
| 2013-12-31 | $962.44 Million | +71.16% |
| 2012-12-31 | $562.29 Million | +34.93% |
| 2011-12-31 | $416.72 Million | -1.01% |
| 2010-12-31 | $420.98 Million | +12.93% |
| 2009-12-31 | $372.76 Million | -5.29% |
| 2008-12-31 | $393.59 Million | -3.59% |
| 2007-12-31 | $408.23 Million | +18.03% |
| 2006-12-31 | $345.87 Million | +6.67% |
| 2005-12-31 | $324.24 Million | +3.42% |
| 2004-12-31 | $313.50 Million | -6.00% |
| 2003-12-31 | $333.50 Million | +47.99% |
| 2002-12-31 | $225.35 Million | +11.31% |
| 2001-12-31 | $202.46 Million | -9.64% |
| 2000-12-31 | $224.07 Million | -32.87% |
| 1999-12-31 | $333.80 Million | -5.12% |
| 1998-12-31 | $351.80 Million | +101.14% |
| 1997-12-31 | $174.90 Million | -21.88% |
| 1996-12-31 | $223.90 Million | +296.99% |
| 1995-12-31 | $56.40 Million | -- |